Sun Pharma and Philogen enter into exclusive agreement for commercialising anti-cancer immunotherapy
- Posted on October 1, 2024
- By Financial Express
- 2 Views
Sun Pharma and Philogen enter into exclusive agreement for commercialising anti-cancer immunotherapy
Under the terms of the agreement, Sun Pharma will have the exclusive worldwide rights to commercialise Fibromun.
